T13080L |
Taranabant
|
701977-09-5
|
99.06%
|
|
Taranabant (MK-0364) is a selective and potent cannabinoid 1 (CB1) receptor inverse agonist used in the study of obesity and nicotine dependence.
|
TN2408 |
Evofolin B
|
1961305-60-1
|
98%
|
|
Evofolin B is a natural compound isolated from the stem bark of Zanthoxylum ailanthoides. Evofolin B has an inhibitory effect on the superoxide anion produced by...
|
T78083 |
CB-25
|
869376-63-6
|
98%
|
|
CB-25 is a partial agonist ligand of CB1 cannabinoid receptors, augmenting Forskolin-induced cAMP formation in cancer cells, though not affecting hCB1-CHO cells ...
|
T78949 |
AM841
|
871978-21-1
|
98%
|
|
AM841, a high-affinity electrophilic ligand, covalently interacts with a cysteine residue in helix six, thus activating the CB1 cannabinoid receptor. It diminish...
|
T79137 |
Monlunabant
|
2712480-46-9
|
98%
|
|
Monlunabant ((S)-MRI-1891), a solid dispersion compound, functions as an inhibitor of the cannabinoid CB1 receptor [1].
|
T79577 |
CB2 PET Radioligand 1
|
|
98%
|
|
CB2 PET Radioligand 1 (compound [18F]9) is a positron emission tomography (PET) radioligand with high affinity for the human cannabinoid receptor 2 (hCB2, Ki=7.7...
|
T79649 |
CB1R/AMPK modulator 1
|
|
98%
|
|
Compound 38-S is an orally active CB1R/AMPK modulator with a K i of 0.81 nM and an IC50 of 3.9 nM for CB1R. This compound activates AMPK and has been shown to de...
|
T79909 |
AEF0117
|
1610878-71-1
|
98%
|
|
AEF0117 is a signaling-specific inhibitor (CB1-SSi) of the cannabinoid receptor 1, playing a crucial role in the management of Cannabis Use Disorder (CUD) [1].
|
T82769 |
CB2R agonist 3
|
|
98%
|
|
CB2R agonist 3, a potent activator of cannabinoid receptor 2 (CB2R), exhibits an EC50 value of 0.37μM, indicative of its significant role in the immune system [1...
|
T82770 |
CB2R agonist 2
|
|
98%
|
|
CB2R agonist 2 (cis-17-para) is a CB2R agonist [1].
|
T83533 |
(R)-Monlunabant
|
2765579-76-6
|
98%
|
|
(R)-Monlunabant ((R)-MRI-1891) serves as a CB1 receptor antagonist utilized in obesity and metabolic disease research [1].
|
TN2766 |
2'-Hydroxydaidzein
|
7678-85-5
|
98%
|
|
2'-Hydroxydaidzein is an isoflavonoid phytonutrient found in plant species, when a natural compound. 2'-Hydroxydaidzein has antioxidant activity, driven mainly b...
|
T13081 |
Taranabant racemate
|
701977-00-6
|
98%
|
|
Taranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor.
|
T75799 |
Hemopressin(human, mouse) TFA
|
1431329-48-4
|
98%
|
|
Hemopressin TFA, a nonapeptide originating from the α1-chain of hemoglobin and initially isolated from rat brain homogenates, is an orally active, selective inve...
|
T62530 |
N-Arachidonyldopamine
|
199875-69-9
|
98%
|
|
N-Arachidonyldopamine (NADA) is a selective and potent endogenous CB1 receptor agonist (Ki: 250 nM).N-Arachidonyldopamine is also a potent and selective TRPV1 ag...
|
T10510 |
CB1 antagonist 1
|
890037-68-0
|
98%
|
|
CB1 antagonist 1 is a CB1 receptor antagonist, used in the research of obesity and metabolic syndrome, neuroinflammatory disorders, cognitive disorders, and gast...
|
T17027 |
Tedalinab
|
916591-01-0
|
98%
|
|
Tedalinab is an effective and selective cannabinoid receptor 2 agonist. Tedalinab has the potential for neuropathic pain and osteoarthritis treatment. Tedalinab ...
|
T14504 |
BAY 38-7271
|
212188-60-8
|
98%
|
|
BAY 38-7271 has strong neuroprotective properties.[1] BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist. With Kis of 1.85 nM an...
|
T64371 |
Virodhamine
|
287937-12-6
|
98%
|
|
Virodhamine (O-arachidonoyl ethanolamine), an endocannabinoid, is an antagonist of CB1 receptor and an agonist of CB2 receptor. Virodhamine can be used for the r...
|
T77634 |
JHU 75528
|
947696-17-5
|
99.97%
|
|
JHU 75528 (JHU-75528) is a novel PET tracer with inhibitory effects on CB that can be used to study the cannabinoid system in schizophrenic patients.
|